Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease
Open Access
- 17 September 2013
- journal article
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 8
Abstract
Background: The aim of this study is to investigate the prevalence of metabolic syndrome (MetS), carotid intima media thickness (IMT), and serum C-reactive protein (CRP) levels in patients with chronic obstructive pulmonary disease (COPD), and the possible relationships among them. Methods: Fifty stable COPD patients and 40 healthy controls were included in the study. The participants were further divided into four groups according to their smoking status. Pulmonary function tests were performed in COPD patients. Anthropometric measurements and blood chemistry analysis, serum CRP levels and carotid intimamedia thickness (IMT) measurements were performed in all the study population. Results: Prevalence of metabolic syndrome was 43% in COPD patients and 30% in the control group (p = 0.173). FEV1% and FEV1/FVC were higher in COPD patients with MetS (p = 0.001 and p = 0.014, respectively) compared to those without MetS. Prevalence of MetS was significantly different among the COPD patients with different stages (p = 0.017) with the highest value in stage 2 (59%). Carotid IMT was significantly higher in COPD patients than in control group (1.07 ± 0.25 mm and 0.86 ± 0.18 mm, respectively; p < 0.001). Serum CRP levels were not different in COPD patients and controls, however they were higher in individuals with MetS compared to those without MetS regardless of COPD presence (p = 0.02). Conclusions: Early markers of atherogenesis, in terms of carotid IMT, were found to be higher in COPD patients than in healthy controls. MetS prevalence was observed to decrease as the severity of airflow obstruction increased. Therefore, screening COPD patients for these cardiovascular risk factors would be a novel approach even in absence of symptoms.Keywords
This publication has 26 references indexed in Scilit:
- From COPD to chronic systemic inflammatory syndrome?The Lancet, 2007
- Prevalence of the metabolic syndrome among Turkish adultsEuropean Journal of Clinical Nutrition, 2006
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- The Metabolic Syndrome in Patients With Chronic Obstructive Pulmonary DiseaseJournal of Cardiopulmonary Rehabilitation, 2005
- Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseACC Current Journal Review, 2003
- Waist Circumference, Visceral Obesity, and Cardiovascular RiskJournal of Cardiopulmonary Rehabilitation, 2003
- Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluationAtherosclerosis, 2002
- Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination SurveyObstetrical & Gynecological Survey, 2002
- Association Between Peak Expiratory Flow and the Development of Carotid Atherosclerotic PlaquesArchives of internal medicine (1960), 2001
- Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the whitehall studyJournal of Clinical Epidemiology, 1988